Next Post

J&J stock sinks after revenue misses and full-year outlook was cut, as drug sales disappoint

Shares of Johnson & Johnson JNJ, -1.25% sank 3.2% in premarket trading Tuesday after the pharmaceutical and purchaser solutions enterprise topped 1st-quarter profit expectations but skipped on income, and slice its whole-yr outlook, as the prescribed drugs small business unhappy. Net profits fell to $5.15 billion, or $1.93 a share, […]
J&J stock sinks after revenue misses and full-year outlook was cut, as drug sales disappoint

Subscribe US Now